MRK
Merck & Co. Inc.Stock · HealthcareDow Jones 1.4% · S&P 500 0.5% · Russell 1000 0.5% · US Stock Market 0.4% · Russell 3000 0.4% · MSCI World 0.3% · MSCI ACWI 0.3% · S&P 500 Equal Weight 0.2%$143.93-0.54%
as of market close, Sep 11, 2026
☾ AH — —
MRK — Merck & Co. Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
60.070.080.090.0100.0110.0120.0130.0140.0150.00100.0M200.0M$143.93—20162019202120242026
2026-09-11
Price$143.93
MA20$125.37
MA50$108.35
Vol46.8M
Key stats
Price data
- Price
- $143.93
- Change YTD
- +38.74%
- Next earnings
- Oct 29, 2026
- Market cap
- 355.1B
- Enterprise value
- 403.1B
- Shares outstanding
- 2.5B
- 52W low
- $77.58
- 52W high
- $156.92
- From 52W high
- -8.28%
- From 52W low
- +85.52%
- 52W range
- 84%
- Beta
- 0.19
Volume
- Rel volume
- 0.84×
- 30D volume
- 10.3M
- 30D $ vol
- 1.5B
Fundamentals
- Sales (ttm)
- 66.6B
- Sales/share
- $26.98
- EPS (ttm)
- $1.28
- FCF (ttm)
- 16.1B
- FCF/share
- $6.51
- Book value/share
- $17.00
- Net margin
- 4.77%
- ROE
- 7.57%
- ROA
- 2.44%
- Debt / equity
- 1.22×
- Current ratio
- 1.32
Growth (CAGR, ttm) · 10Y
- Sales
- +4.65%+4.51%+8.68%+5.56%
- Net income
- -80.68%+0.66%-10.65%-4.70%
- FCF
- +9.12%+14.05%+17.76%+4.99%
- Shares
- -1.23%-0.93%-0.51%-1.13%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -80.30%+1.47%-10.23%-3.51%
- Sales/share
- +5.94%+5.50%+9.24%+6.76%
- FCF/share
- +10.47%+15.12%+18.34%+6.20%
- Book value/share
- -13.36%+3.68%+5.26%+0.81%
- Dividend/share
- +5.00%+5.27%+5.59%+6.27%
- Price
- +69.09%+9.84%+14.40%+9.21%
- Total return
- +74.75%+13.28%+18.02%+12.61%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 112.6×
- Fwd P/E
- 15.7×
- P/S (ttm)
- 5.3×
- P/B (mrq)
- 8.5×
- P/FCF (ttm)
- 22.1×
- EV/EBITDA (fy)
- 29.4×
- EV/Sales (ttm)
- 6.1×
- FCF yield (ttm)
- 4.52%
- Dividend yield (fwd)
- 2.33%
- Dividend/share (fwd)
- $3.36
- Buyback yield (realized, 1y)
- 1.23%
- Shareholder yield (realized, 1y)
- 5.42%
- Buyback yield (cash, ttm)
- 1.18%
- Shareholder yield (cash, ttm)
- 3.52%
Vs own 10Y history
- P/E
- 92nd
- P/S
- 95th
- P/B
- 98th
- P/FCF
- 46th
Bar = where today’s multiple sits in MRK’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · windows as of 2026-09-11
1D
-0.54%
5D
-5.52%
1M
+8.28%
3M
+20.04%
YTD
+38.74%
1Y
+77.01%
5Y
+118.13%
Financial statements
Open full MRK financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -8.44% | -0.65% |
| JNJ | Johnson & Johnson | +2.31% | -0.29% |
| ABBV | AbbVie Inc. | +3.36% | +0.83% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -6.53% | -2.37% |
| TMO | Thermo Fisher Scientific Inc. | +1.13% | +1.10% |
| AMGN | Amgen Inc. | -8.80% | -1.34% |
| GILD | Gilead Sciences Inc. | +5.78% | -0.75% |
| ABT | Abbott Laboratories | -8.08% | -1.36% |
Merck & Co. Inc. (MRK) trades at $143.93 with a live price and an interactive chart covering 56+ years of daily price history, plus key valuation metrics. ChartRow also publishes MRK’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full MRK financial statements →
